Upregulated |
|
|
|
GO:0030198 |
integrin-mediated signaling pathway |
21 |
1.05E-14 |
GO:0030574 |
collagen catabolic process |
14 |
6.69E-14 |
KEGG:hsa04512 |
ECM-receptor interaction |
13 |
1.88E-10 |
GO:0004222 |
metalloendopeptidase activity |
12 |
1.65E-08 |
GO:0030199 |
collagen fibril organization |
8 |
1.17E-07 |
KEGG:hsa04510 |
Focal adhesion |
14 |
4.69E-07 |
KEGG:hsa05146 |
Amoebiasis |
10 |
2.82E-06 |
GO:0005201 |
extracellular matrix structural constituent |
8 |
4.49E-06 |
GO:0004252 |
serine-type endopeptidase activity |
13 |
9.59E-06 |
KEGG:hsa04151 |
PI3K-Akt signaling pathway |
15 |
2.96E-05 |
GO:0005581 |
collagen trimer |
8 |
3.05E-05 |
GO:0031581 |
hemidesmosome assembly |
4 |
2.13E-04 |
KEGG:hsa04974 |
protein digestion and absorption |
7 |
4.74E-04 |
GO:0007229 |
integrin-mediated signaling pathway |
7 |
5.24E-04 |
GO:0005788 |
endoplasmic reticulum lumen |
9 |
5.65E-04 |
GO:0006508 |
proteolysis |
15 |
6.11E-04 |
GO:0007160 |
cell-matrix adhesion |
6 |
0.00226 |
KEGG:hsa05222 |
small cell lung cancer |
6 |
0.002763 |
KEGG:hsa05200 |
Pathways in cancer |
12 |
0.004792 |
GO:0043588 |
skin development |
4 |
0.004925 |
GO:0048333 |
mesodermal cell differentiation |
3 |
0.005338 |
Downregulated |
|
|
|
GO:0003756 |
protein disulfide isomerase activity |
3 |
0.001837 |